RxDoctor Payments Data

Catherine Mercado, MD

Radiation Oncology · Orlando, FLNPI 1841605946

Payments from drug & device makers

$7,332in general payments, 2019–2025

Across 15 payments — averaging $488.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GT Medical Technologies, Inc$5K
  • Siemens Medical Solutions USA, Inc.$2K
  • Novocure Inc.$190
  • Boston Scientific$59
  • Mevion_medical_systems_inc$55
  • Teleflex LLC$38
  • plus $17 from 1 others

What the payments were for

  • Speaking & faculty fees$2,00081%
  • Food & beverage$47219%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GT Medical Technologies, Inc5$4,975
Siemens Medical Solutions USA, Inc.1$2,000
Novocure Inc.2$190
Boston Scientific3$59
Mevion_medical_systems_inc2$55
Teleflex LLC1$38
Brainlab, Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,332 in reported general payments places this provider in the 80th percentile of 465 radiation oncology providers in Florida.

See all radiation oncology providers in Florida

Medicare billing

Part B allowed, 2024
$155,684
Medicare patients
227
Services billed
1,738

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl74$645
Levetiracetam15$582
Memantine Hcl26$531
Dexamethasone39$404
Ciprofloxacin Hcl42$121
Famotidine26$108
Lorazepam13$16

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →